blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1285578

EP1285578 - Transgenic animal model of Alzheimer's disease [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.09.2008
Database last updated on 20.09.2024
Most recent event   Tooltip13.08.2010Lapse of the patent in a contracting state
New state(s): TR		published on 15.09.2010  [2010/37]
Applicant(s)For all designated states
SMITHKLINE BEECHAM PLC
980 Great West Road Brentford
Middlesex TW8 9GS / GB
[2007/44]
Former [2003/09]For all designated states
SMITHKLINE BEECHAM PLC
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Inventor(s)01 / Geppert, Martin, c/o GlaxoSmithKline
New Frontiers Science Park
Harlow, Essex CM19 5AW / GB
02 / Harper, Alexander James, c/o GlaxoSmithKline
New Frontiers Science Park
Harlow, Essex CM19 5AW / GB
03 / Harrison, Steve Mark, c/o GlaxoSmithKline
New Frontiers Science Park
Harlow, Essex CM19 5AW / GB
04 / Prosser, Hayon, c/o GlaxoSmithKline
New Frontiers Science Park
Harlow, Essex CM19 5AW / GB
 [2003/09]
Representative(s)Giddings, Peter John
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2003/09]Giddings, Peter John, Dr.
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date02078428.620.08.2002
[2003/09]
Priority number, dateGB2001002034221.08.2001         Original published format: GB 0120342
GB2001002672307.11.2001         Original published format: GB 0126723
[2003/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1285578
Date:26.02.2003
Language:EN
[2003/09]
Type: A3 Search report 
No.:EP1285578
Date:17.09.2003
[2003/38]
Type: B1 Patent specification 
No.:EP1285578
Date:31.10.2007
Language:EN
[2007/44]
Search report(s)(Supplementary) European search report - dispatched on:EP07.08.2003
ClassificationIPC:A01K67/027, C12N15/57, C12N15/85, C12N15/89, C12Q1/37, G01N33/50, C07K14/47
[2003/38]
CPC:
C12N15/8509 (EP,US); A01K67/0275 (EP,US); C07K14/4711 (EP,US);
C12N9/6478 (EP,US); A01K2217/05 (EP,US); A01K2227/105 (EP,US);
A01K2267/0312 (EP,US); C12N2830/008 (EP,US); C12N2830/85 (EP,US);
C12N2840/203 (EP,US) (-)
Former IPC [2003/09]A01K67/027, C12N15/57, C12N15/85, C12N15/89, C12Q1/37, G01N33/50
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2003/09]
TitleGerman:Transgenes Tiermodell für Alzheimer-Erkrankung[2003/09]
English:Transgenic animal model of Alzheimer's disease[2003/09]
French:Modèle animal transgénique pour la maladie d'Alzheimer[2003/09]
Examination procedure20.08.2002Examination requested  [2003/09]
08.08.2005Despatch of a communication from the examining division (Time limit: M06)
02.02.2006Reply to a communication from the examining division
28.02.2006Despatch of a communication from the examining division (Time limit: M06)
07.09.2006Reply to a communication from the examining division
07.03.2007Communication of intention to grant the patent
04.07.2007Fee for grant paid
04.07.2007Fee for publishing/printing paid
Opposition(s)01.08.2008No opposition filed within time limit [2008/41]
Fees paidRenewal fee
06.08.2004Renewal fee patent year 03
08.08.2005Renewal fee patent year 04
07.08.2006Renewal fee patent year 05
03.08.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT31.10.2007
CH31.10.2007
CY31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
SK31.10.2007
TR31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
[2010/37]
Former [2009/33]AT31.10.2007
CH31.10.2007
CY31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2009/22]AT31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2009/15]AT31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2009/13]AT31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2008/39]AT31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
LI31.10.2007
NL31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/35]AT31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
LI31.10.2007
NL31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/29]AT31.10.2007
CH31.10.2007
LI31.10.2007
NL31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/24]CH31.10.2007
LI31.10.2007
NL31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/23]CH31.10.2007
LI31.10.2007
NL31.10.2007
SE31.01.2008
Documents cited:Search[Y]  - HARPER A J ET AL, "Mouse models for AD;characterisation of beta-secretase (Asp2) overexpressing mice using a novel gene expression strategy.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, 31st Annual Meeting of the Society for Neuroscience;San Diego, California, USA; November 10-15, 2001, (2001), vol. 27, no. 1, ISSN 0190-5295, page 852, XP009013867 [Y] 1-13 * abstract *
 [Y]  - HERNANDEZ-SANCHEZ CATALINA ET AL, "Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, March 13, 2001, (20010313), vol. 98, no. 6, ISSN 0027-8424, pages 3549 - 3554, XP002247671 [Y] 1-13 * page 3553, column 2, paragraph 3 - page 3554, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1073/pnas.051012898
 [YD]  - TANG Y-P ET AL, "Genetic enhancement of learning and memory in mice", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, (19990902), vol. 401, no. 6748, ISSN 0028-0836, pages 63 - 69, XP002199188 [YD] 1-13 * page 62, column 1, paragraph 3 *

DOI:   http://dx.doi.org/10.1038/43432
 [A]  - SKOVRONSKY D M ET AL, "beta-Secretase revealed: starting gate for race to novel therapies for Alzheimer's disease", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, (200005), vol. 21, no. 5, ISSN 0165-6147, pages 161 - 163, XP004198178 [A] * page 162, column 2, paragraph 3 - column 3, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/S0165-6147(00)01467-X
 [A]  - JANUS C ET AL, "TRANSGENIC MOUSE MODELS OF ALZHEIMER'S DISEASE", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, NL, (20000726), vol. 1502, no. 1, ISSN 0006-3002, pages 63 - 75, XP001018988
 [DA]  - HUSSAIN I ET AL, "IDENTIFICATION OF A NOVEL ASPARTIC PROTEASE (ASP 2) AS SS-SECRETASE", MOLECULAR AND CELLULAR NEUROSCIENCES, SAN DIEGO, US, (1999), vol. 14, no. 6, ISSN 1044-7431, pages 419 - 427, XP000908710 [DA] * the whole document *

DOI:   http://dx.doi.org/10.1006/mcne.1999.0811
ExaminationWO0047618
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.